SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001711576-19-000003
Filing Date
2019-04-15
Accepted
2019-04-15 16:17:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A schedule13da1-waltersxhoff.htm SC 13D/A 85174
  Complete submission text file 0001711576-19-000003.txt   86674
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88094 | Film No.: 19748783
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DARE BIOSCIENCE, INC. 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Walters-Hoffert Lisa (Filed by) CIK: 0001711576 (see all company filings)

Type: SC 13D/A